QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=797D32418FBBE0ACCF3EF2802A7B668A;jsessionid=4E67DE543DAC5E64F22F3B43FE1C8ACD;jsessionid=2EF589DB3501616F8EEFE3FDD90B0863;jsessionid=2DB7D3F35E2F3461947AE75188BAFA63;jsessionid=F651AF12D7D08461FDB090DDBC7FD42F (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=797D32418FBBE0ACCF3EF2802A7B668A;jsessionid=4E67DE543DAC5E64F22F3B43FE1C8ACD;jsessionid=2EF589DB3501616F8EEFE3FDD90B0863;jsessionid=2DB7D3F35E2F3461947AE75188BAFA63;jsessionid=F651AF12D7D08461FDB090DDBC7FD42F